Financials
- Market Capitalization 447.44 M
- Employee 22
- Founded 2017
- CEO N/A
- Website www.q32bio.com
- Headquarter Delaware, United States
- FIGI BBG00CTTJWQ9
- Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
1.37
Relación precio/flujo de caja
0.76
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2742 | CBIO Crescent Biopharma, Inc. - Common Stock | 17.75 USD | -0.06% | +3.50% | +21.08% | +22.50% | 659.30 M USD | ||
| 2815 | EIKN Eikon Therapeutics, Inc. - Common Stock | 10.98 USD | -4.69% | -4.69% | +21.33% | -35.60% | 594.73 M USD | ||
| 3145 | UPB Upstream Bio, Inc. - Common Stock | 6.69 USD | -1.47% | -4.43% | +5.35% | -59.84% | 366.42 M USD | ||
| 3336 | AMRN Amarin Corporation plc - American Depositary Shares, each repre | 13.97 USD | -0.71% | -0.85% | -1.13% | -10.22% | 295.09 M USD |